4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000899243-18-007825
Chief Executive Officer sold 100,000 shares at $24.75 ($2,475,000)
- Chief Executive Officer acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Quart Barry D · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-03-14 | Exercise or conversion : show line 1 in the form | +100,000 | $7.20 | $720,000 | 167,993 | D |
| 2018-03-14 | Sale : show line 2 in the form | −100,000 | $24.75 | $2,475,000 | 67,993 | D |
| Open-market sales · 100,000 sh · avg $24.75 · $2,475,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-03-14 | Exercise or conversion : show line 3 in the form Employee Stock Option(Right to Buy) | −100,000 | $7.20 | 2023-05-01 | 100,000 | 830,276 | D |
Loading xslF345X03/doc4.xml…